Predictive Vulnerability Intelligence.

Product

  • Product
  • Pricing
  • Documentation

Company

  • About
  • Partnerships
  • Blog
  • Support

Legal

  • Terms
  • Privacy
  • Data Licensing

© 2026 FAUCET Technologies LLC. All rights reserved.

CVE-2017-18223

26
FAUCET Score

CVE-2017-18223 describes a critical authentication bypass vulnerability in BMC Remedy AR System before version 9.1 SP3, allowing unauthenticated attackers to gain administrative access when Remedy AR Authentication is enabled. With a CVSS score of 8.1 (High), this flaw presents a significant risk due to its network-based attack vector, low attack complexity, and high impact on confidentiality, integrity, and availability. Despite its severity, there is no public exploit code available, nor is it listed in CISA's KEV catalog, and it has garnered minimal community discussion or media coverage.

Impacted Technologies

VendorProductVersion(s)CPE
< 9.1.03CPE matchmatch criteria
cpe:2.3:a:bmc:remedy_action_request_system:*:*:*:*:*:*:*:*

CVSS Data

CVSS version used by this source: 3.0

8.1HIGH

CVSS:3.0/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:H

Attack Vector
NETWORK
Attack Complexity
HIGH
Privileges Required
NONE
User Interaction
NONE
Scope
UNCHANGED
Confidentiality Impact
HIGH
Integrity Impact
HIGH
Availability Impact
HIGH
Exploitability Score
2.2
Impact Score
5.9
CvssVersion
3.0

Exploit Intelligence

EPSS Score
0.98%
Probability of exploitation in next 30 days
EPSS Percentile
58.7%
Percentile rank of EPSS score among Peer Group
As of 2026-07-27
Model: v2026.06.15
This CVE's current EPSS score of 0.0098 is in the 23rd percentile among its peer group of 8,920 CVEs.

Social Chatter

The average CVE in this peer group has 0.0 Twitter, 0.1 Reddit, 0.1 Bluesky, 0.1 Mastodon, and 0.2 GitHub mentions.

Media Mentions

No media coverage found for this CVE.

The average CVE in this peer group has 0.1 InfoSec Media, 0.0 Vendor Blog, and 0.0 Security Researcher mentions.

Remediation

Remediation records are not available for this CVE.

References

communities.bmc.com / thread/165887
Vendor Advisory